Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II–III chronic kidney disease

AIMS: Clinical trials suggest that statins have beneficial effects on the cardiovascular system independent from their cholesterol lowering properties. In patients with chronic kidney disease stage II–III, we tested the hypothesis that atorvastatin increased systemic and renal nitric oxide (NO) avai...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Br J Clin Pharmacol
Главные авторы: Mose, Frank Holden, Larsen, Thomas, Jensen, Janni Majgaard, Hansen, Annebirthe Bo, Bech, Jesper Nørgaard, Pedersen, Erling Bjerregaard
Формат: Artigo
Язык:Inglês
Опубликовано: BlackWell Publishing Ltd 2014
Предметы:
Clinical Trials
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239973/
https://ncbi.nlm.nih.gov/pubmed/24697877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12390
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы